List of Myoview drug patents

Myoview is owned by Ge Healthcare.

Myoview contains Technetium Tc-99M Tetrofosmin Kit.

Myoview has a total of 1 drug patent out of which 0 drug patents have expired.

Myoview was authorised for market use on 09 February, 1996.

Myoview is available in injectable;injection dosage forms.

The generics of Myoview are possible to be released after 10 March, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9549999 GE HEALTHCARE Radiopharmaceutical composition
Mar, 2030

(6 years from now)

Drugs and Companies using TECHNETIUM TC-99M TETROFOSMIN KIT ingredient

Market Authorisation Date: 09 February, 1996

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

MYOVIEW family patents

2

United States

2

European Union

1

Hong Kong

1

Japan

1

Spain

1

China

1

United Kingdom

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic